Request Deal Involvement
UCB completed the acquisition of Zogenix for $1.9bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
LifeSci Partners
legal advisors
Latham & Watkins
financial advisors
Leerink Partners
financial advisors
Bank of America
legal advisors to financial advisors
Fried Frank Harris Shriver & Jacobson
financial advisors
Barclays
financial advisors
Lazard
legal advisors
Covington & Burling
or
Principals
target
ZOGENIX INC
bidder
UCB PHARMA SA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite